glp 1 agonist contraindications Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus GLP-1 Receptor Agonists | New

Parsons, G

The diabetes drugs that are changing how we diet Lets start with the basics

Setting realistic expectations early can also prevent unnecessary discontinuation

10.3389/fnmol.2022.908948 68 TuestaL

investigated the effects of incretins, including GIP (gastric inhibitory polypeptide) and GLP-1, on ovarian steroidogenesis on rat primary GCs

In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)